Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 375986, 13 pages
http://dx.doi.org/10.1155/2014/375986
Research Article

Yi Qi Qing Re Gao Attenuates Podocyte Injury and Inhibits Vascular Endothelial Growth Factor Overexpression in Puromycin Aminonucleoside Rat Model

1Department of Nephrology, Guang'anmen Hospital of China Academy of Traditional Chinese Medical Sciences, No. 5 Beixiange, Xicheng District, Beijing 100053, China
2Beijing University of Chinese Medicine, No. 11 Beisanhuan Donglu, Chaoyang District, Beijing 100029, China
3Department of Pharmacology, Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, No. 2 Yinghua Dongjie, Hepingli, Beijing 100029, China

Received 23 January 2014; Revised 24 April 2014; Accepted 26 April 2014; Published 21 May 2014

Academic Editor: Yoshiji Ohta

Copyright © 2014 Yongli Zhan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. R. Hemmelgarn, B. J. Manns, A. Lloyd et al., “Relation between kidney function, proteinuria, and adverse outcomes,” Journal of the American Medical Association, vol. 303, no. 5, pp. 423–429, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. J. E. Toblli, P. Bevione, F. Di Gennaro, L. Madalena, G. Cao, and M. Angerosa, “Understanding the mechanisms of proteinuria: therapeutic implications,” International Journal of Nephrology, vol. 2012, Article ID 546039, 13 pages, 2012. View at Publisher · View at Google Scholar
  3. P. W. Mathieson, “Update on the podocyte,” Current Opinion in Nephrology and Hypertension, vol. 18, no. 3, pp. 206–211, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Pavenstadt, W. Kriz, and M. Kretzler, “Cell biology of the glomerular podocyte,” Physiological Reviews, vol. 83, no. 1, pp. 253–307, 2003. View at Google Scholar · View at Scopus
  5. P. Aaltonen and H. Holthofer, “The nephrin-based slit diaphragm: new insight into the signalling platform identifies targets for therapy,” Nephrology Dialysis Transplantation, vol. 22, no. 12, pp. 3408–3410, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. A. M. Kuusniemi, J. Merenmies, A. T. Lahdenkari et al., “Glomerular sclerosis in kidneys with congenital nephrotic syndrome (NPHS1),” Kidney International, vol. 70, no. 8, pp. 1423–1431, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Patrakka, M. Kestila, J. Wartiovaara et al., “Congenital nephrotic syndrome (NPHS1): features resulting from different mutations in Finnish patients,” Kidney International, vol. 58, no. 3, pp. 972–980, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. Kim, H. Wu, G. Green et al., “CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility,” Science, vol. 300, no. 5623, pp. 1298–1300, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Wolf and R. A. Stahl, “CD2-associated protein and glomerular disease,” The Lancet, vol. 362, no. 9397, pp. 1746–1748, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Yaddanapudi, M. M. Altintas, A. D. Kistler et al., “CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival,” Journal of Clinical Investigation, vol. 121, no. 10, pp. 3965–3980, 2011. View at Publisher · View at Google Scholar
  11. H. G. Kang, K. H. Paik, H. Y. Cho et al., “Transcriptome analysis of the response of cultured murine podocytes to puromycin aminonucleoside,” Nephron—Experimental Nephrology, vol. 115, no. 1, pp. e1–e8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Inoue, E. Yaoita, H. Kurihara et al., “FAT is a component of glomerular slit diaphragms,” Kidney International, vol. 59, no. 3, pp. 1003–1012, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Schnabel, J. M. Anderson, and M. G. Farquhar, “The tight junction protein ZO-1 is concentrated along slit diaphragms of the glomerular epithelium,” Journal of Cell Biology, vol. 111, no. 3, pp. 1255–1263, 1990. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Doyonnas, D. B. Kershaw, C. Duhme et al., “Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin,” The Journal of Experimental Medicine, vol. 194, no. 1, pp. 13–27, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Eremina, H. J. Baelde, and S. E. Quaggin, “Role of the VEGF-A signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier,” Nephron Physiology, vol. 106, no. 2, pp. p32–p37, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Guan, G. Villegas, J. Teichman, P. Mundel, and A. Tufro, “Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP,” The American Journal of Physiology: Renal Physiology, vol. 291, no. 2, pp. F422–F428, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Sison, V. Eremina, H. Baelde et al., “Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling,” Journal of the American Society of Nephrology, vol. 21, no. 10, pp. 1691–1701, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Bertuccio, D. Veron, P. K. Aggarwal, L. Holzman, and A. Tufro, “Vascular endothelial growth factor receptor 2 direct interaction with nephrin links VEGF-A signals to actin in kidney podocytes,” Journal of Biological Chemistry, vol. 286, no. 46, pp. 39933–39944, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Nakajo, J. Khoshnoodi, H. Takenaka et al., “Mizoribine corrects defective nephrin biogenesis by restoring intracellular energy balance,” Journal of the American Society of Nephrology, vol. 18, no. 9, pp. 2554–2564, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Veron, K. Reidy, A. Marlier et al., “Induction of podocyte VEGF164 overexpression at different stages of development causes congenital nephrosis or steroid-resistant nephrotic syndrome,” The American Journal of Pathology, vol. 177, no. 5, pp. 2225–2233, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Zhan and X. Dai, “Treatment of 30 cases with chronic nephritis with replenishing qi, removing blood stasis, clearing heat and toxin methods,” Journal of Traditional Chinese Medicine, vol. 44, no. 12, pp. 922–924, 2003. View at Google Scholar
  22. Y. Zhan, X. Dai, X. Li, S. Li, and X. Rao, “Renoprotective effect of Yiqiqingre extract in Adriamycin nephritic rats,” Chinese Journal of Integrated Traditional and Western Nephrology, vol. 4, no. 3, pp. 135–138, 2003. View at Google Scholar
  23. H. Zhang, T. Zhao, Y. Gong et al., “Attenuation of diabetic nephropathy by Chaihuang-Yishen granule through anti-inflammatory mechanism in streptozotocin-induced rat model of diabetics,” Journal of Ethnopharmacology, vol. 151, no. 1, pp. 556–564, 2014. View at Publisher · View at Google Scholar
  24. T. Schmittgen and K. Livak, “Analyzing real-time PCR data by the comparative C(T) method,” Nature Protocols, vol. 3, no. 6, pp. 1101–1108, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Tylicki, S. Lizakowski, and B. Rutkowski, “Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions,” Journal of Nephrology, vol. 25, no. 6, pp. 900–910, 2012. View at Publisher · View at Google Scholar
  26. S. Inokuchi, I. Shirato, N. Kobayashi, H. Koide, Y. Tomino, and T. Sakai, “Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis,” Kidney International, vol. 50, no. 4, pp. 1278–1287, 1996. View at Publisher · View at Google Scholar
  27. S. Kummer, S. Jeruschke, L. van Wegerich et al., “Estrogen receptor alpha expression in podocytes mediates protection against apoptosis in-vitro and in-vivo,” PLoS ONE, vol. 6, no. 11, Article ID e27457, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Wen, L. You, Q. Zhang et al., “Upregulation of nestin protects podocytes from apoptosis induced by puromycin aminonucleoside,” The American Journal of Nephrology, vol. 34, no. 5, pp. 423–434, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Shibata, M. Nagase, and T. Fujita, “Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling,” Journal of the American Society of Nephrology, vol. 17, no. 3, pp. 754–764, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Suzuki, T. Ito, E. Imai et al., “Retinoids regulate the repairing process of the podocytes in puromycin aminonucleoside-induced nephrotic rats,” Journal of the American Society of Nephrology, vol. 14, no. 4, pp. 981–991, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Hosoyamada, K. Yan, Y. Nishibori et al., “Nephrin and podocin expression around the onset of puromycin aminonucleoside nephrosis,” Journal of Pharmacological Sciences, vol. 97, no. 2, pp. 234–241, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. G. D. Han, K. Suzuki, H. Koike et al., “IFN-inducible protein-10 plays a pivotal role in maintaining slit-diaphragm function by regulating podocyte cell-cycle balance,” Journal of the American Society of Nephrology, vol. 17, no. 2, pp. 442–453, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Stratakis, K. Stylianou, I. Petrakis et al., “Rapamycin ameliorates proteinuria and restores nephrin and podocin expression in experimental membranous nephropathy,” Clinical and Developmental Immunology, vol. 2013, Article ID 941893, 8 pages, 2013. View at Publisher · View at Google Scholar
  34. M. Kestila, U. Lenkkeri, M. Mannikko et al., “Positionally cloned gene for a novel glomerular protein—nephrin—is mutated in congenital nephrotic syndrome,” Molecular Cell, vol. 1, no. 4, pp. 575–582, 1998. View at Google Scholar · View at Scopus
  35. K. Yan, J. Khoshnoodi, V. Ruotsalainen, and K. Tryggvason, “N-linked glycosylation is critical for the plasma membrane localization of nephrin,” Journal of the American Society of Nephrology, vol. 13, no. 5, pp. 1385–1389, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Tufro, “VEGF spatially directs angiogenesis during metanephric development in vitro,” Developmental Biology, vol. 227, no. 2, pp. 558–566, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. T. V. Patel, J. A. Morgan, G. D. Demetri et al., “A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib,” Journal of the National Cancer Institute, vol. 100, no. 4, pp. 282–284, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. D. Veron, K. J. Reidy, C. Bertuccio et al., “Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease.,” Kidney International, vol. 77, no. 11, pp. 989–999, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. J. C. Yang, L. Haworth, R. M. Sherry et al., “A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer,” The New England Journal of Medicine, vol. 349, no. 5, pp. 427–434, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Fan, T. Wakayama, S. Yokoyama, O. Amano, and S. Iseki, “Downregulation of vascular endothelial growth factor and its receptors in the kidney in rats with puromycin aminonucleoside nephrosis,” Nephron, vol. 90, no. 1, pp. 95–102, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. G. A. Sivaskandarajah, M. Jeansson, Y. Maezawa, V. Eremina, H. J. Baelde, and S. E. Quaggin, “Vegfa protects the glomerular microvasculature in diabetes,” Diabetes, vol. 61, no. 11, pp. 2958–2966, 2012. View at Publisher · View at Google Scholar
  42. J. Kanellis, V. Levidiotis, T. Khong et al., “A study of VEGF and its receptors in two rat models of proteinuria,” Nephron Physiology, vol. 96, no. 1, pp. P26–P36, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. B. Hohenstein, M. Colin, C. Foellmer et al., “Autocrine VEGF-VEGF-R loop on podocytes during glomerulonephritis in humans,” Nephrology Dialysis Transplantation, vol. 25, no. 10, pp. 3170–3180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Ostendorf, U. Kunter, F. Eitner et al., “VEGF(165) mediates glomerular endothelial repair,” Journal of Clinical Investigation, vol. 104, no. 7, pp. 913–923, 1999. View at Google Scholar · View at Scopus
  45. J. Ma, T. Matsusaka, H. C. Yang et al., “Induction of podocyte-derived VEGF ameliorates podocyte injury and subsequent abnormal glomerular development caused by puromycin aminonucleoside,” Pediatric Research, vol. 70, no. 1, pp. 83–89, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Ke, X. Q. Hu, J. Ouyang, B. Dai, and Y. Xu, “The effect of astragalin on the VEGF production of cultured Muller cells under high glucose conditions,” Bio-Medical Materials and Engineering, vol. 22, no. 1–3, pp. 113–119, 2012. View at Publisher · View at Google Scholar
  47. K. K. Auyeung, P. K. Woo, P. C. Law, and J. K. Ko, “Astragalus saponins modulate cell invasiveness and angiogenesis in human gastric adenocarcinoma cells,” Journal of Ethnopharmacology, vol. 141, no. 2, pp. 635–641, 2012. View at Publisher · View at Google Scholar
  48. R. Zheng, Y. Deng, Y. Chen et al., “Astragaloside IV attenuates complement membranous attack complex induced podocyte injury through the MAPK pathway,” Phytotherapy Research, vol. 26, no. 6, pp. 892–898, 2012. View at Publisher · View at Google Scholar
  49. D. Gui, J. Huang, Y. Guo et al., “Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-kappaB-mediated inflammatory genes expression,” Cytokine, vol. 61, no. 3, pp. 970–977, 2013. View at Publisher · View at Google Scholar
  50. G. S. Patten, M. Y. Abeywardena, and L. E. Bennett, “Inhibition of angiotensin converting enzyme, angiotensin II receptor blocking and blood pressure lowering bioactivity across plant families,” Critical Reviews in Food Science and Nutrition, 2013. View at Publisher · View at Google Scholar
  51. H. Y. Wang, J. Z. Li, J. S. Pan et al., “The effect of Astragali and Angelica on nephrotic syndrome and its mechanisms of action,” Journal of Beijing Medical University, vol. 34, no. 5, pp. 542–552, 2002. View at Google Scholar
  52. T. F. Tzeng, S. S. Liou, C. J. Chang, and I. M. Liu, “The ethanol extract of Lonicera japonica (Japanese honeysuckle) attenuates diabetic nephropathy by inhibiting p-38 MAPK activity in streptozotocin-induced diabetic rats,” Planta Medica, vol. 80, no. 2-3, pp. 121–129, 2014. View at Publisher · View at Google Scholar
  53. J. Lin, L. Wei, W. Xu, Z. Hong, X. Liu, and J. Peng, “Effect of Hedyotis Diffusa Willd extract on tumor angiogenesis,” Molecular Medicine Reports, vol. 4, no. 6, pp. 1283–1288, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Lin, L. Wei, A. Shen et al., “Hedyotis diffusa Willd extract suppresses Sonic hedgehog signaling leading to the inhibition of colorectal cancer angiogenesis,” International Journal of Oncology, vol. 42, no. 2, pp. 651–656, 2013. View at Publisher · View at Google Scholar
  55. T. Wang, R. C. Choi, J. Li et al., “Antihyperlipidemic effect of protodioscin, an active ingredient isolated from the rhizomes of dioscorea nipponica,” Planta Medica, vol. 76, no. 15, pp. 1642–1646, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. X. Sun, L. Yang, Y. Zhan et al., “Dioscin ameliorates lipopolysaccharide-stimulated rat mesangial cell proliferation through suppressing wnt pathway and TGF-β1 expression,” China Journal of Traditional Chinese Medicine and Pharmacy, vol. 29, no. 3, pp. 871–874, 2014. View at Google Scholar